Related Experiment Video
Updated: Aug 11, 2026
Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP
M Iijima1, M Yamamoto, M Hirayama
1Department of Neurology, Nagoya University Graduate School of Medicine, Tsurumai, Nagoya, Japan.
Insights
Identifying factors for IV immunoglobulin (IVIg) treatment success in chronic inflammatory demyelinating polyneuropathy (CIDP) is crucial. Non-responders often show muscle atrophy and nerve dysfunction, indicating IVIg unresponsiveness.
Area of Science:
- Neurology
- Immunology
- Clinical Electrophysiology
Background:
- Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare autoimmune disorder affecting peripheral nerves.
- Intravenous immunoglobulin (IVIg) is a primary treatment for CIDP, but response varies significantly among patients.
Purpose of the Study:
- To determine clinical and electrophysiologic predictors of IVIg responsiveness in CIDP patients.
- To identify characteristics associated with IVIg unresponsiveness in this population.
Main Methods:
- A multicenter study involving 312 patients diagnosed with CIDP.
- Categorization of patients into IVIg responders (199) and non-responders (113).
- Analysis of clinical features and electrophysiologic findings to identify differentiating factors.
Main Results:
- IVIg non-responders exhibited more pronounced muscle atrophy and reduced compound muscle action potentials.
- Factors associated with IVIg unresponsiveness included male gender, longer disease duration, and slow symptom progression.
- Evidence of axonal dysfunction in peripheral nerves was a key indicator of IVIg unresponsiveness.
Conclusions:
- Clinical and electrophysiologic features can predict IVIg responsiveness in CIDP.
- Axonal dysfunction, muscle atrophy, and specific demographic/disease characteristics are linked to poor IVIg response.
- These findings may aid in tailoring CIDP treatment strategies and managing patient expectations.
Abstract:
To identify clinical and electrophysiologic features related to IV immunoglobulin (IVIg) responsiveness in chronic inflammatory demyelinating polyneuropathy (CIDP), the authors conducted a multicenter study on 312 patients with CIDP (199 responders and 113 nonresponders). Muscle atrophy and decreased compound muscle action potential were pronounced in nonresponders of IVIg. Male gender, longer disease duration, and slow progression of symptoms were also associated with IVIg unresponsiveness. Features suggesting axonal dysfunction in peripheral nerves indicated IVIg unresponsiveness in CIDP.
